While additional mechanistic investigations are essential to fully elucidate MMP14’s regulatory roles, the current work establishes a fundamental framework for developing targeted therapeutic strategies to counteract fibrotic progression in GO. This evidence concerns the gene MMP14 and geroderma osteodysplastica.